Table 2 Proportion of fatty acids in serum phospholipids in primary ventricular fibrillation (PVF) cases and matched controls at hospital admission for STEMI.

From: Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillation

Fatty acid

PVF cases

(n = 58)

Non-PVF controls

(n = 116)

Nominal P-value

FDR-corrected P-value

Cohen’s d

C14:0

3.26 ± 2.09

2.90 ± 2.20

0.151

0.802

− 0.17

C16:0

29.06 ± 3.62

28.55 ± 4.00

0.379

0.802

− 0.13

C16:1n-7cis

1.48 ± 1.21

1.33 ± 0.92

0.273

0.802

− 0.15

C18:0

13.44 ± 3.62

12.96 ± 3.06

0.487

0.802

− 0.14

C18:1n-9cis

18.87 ± 6.65

18.16 ± 7.07

0.418

0.802

− 0.10

C18:2n-6

17.08 ± 3.27

19.20 ± 4.53

0.002

0.027

0.51

C18:3n-3

0.28 ± 0.18

0.31 ± 0.42

0.513

0.802

0.06

C20:0

0.14 ± 0.08

0.13 ± 0.07

0.605

0.802

− 0.11

C20:2n-6

0.29 ± 0.08

0.31 ± 0.09

0.250

0.802

0.19

C20:3n-6

2.56 ± 0.99

2.67 ± 1.11

0.752

0.802

0.10

C20:4n-6

8.62 ± 3.00

8.61 ± 3.35

0.668

0.802

− 0.01

C20:5n-3

0.60 ± 0.37

0.56 ± 0.37

0.366

0.802

− 0.09

C22:0

0.10 ± 0.05

0.12 ± 0.13

0.618

0.802

0.14

C22:4n-6

0.31 ± 0.13

0.31 ± 0.12

0.804

0.802

− 0.06

C22:5n-3

0.22 ± 0.09

0.22 ± 0.10

0.610

0.802

− 0.06

C22:5n-6

0.55 ± 0.16

0.54 ± 0.17

0.587

0.802

− 0.02

C22:6n-3

3.14 ± 1.10

3.14 ± 1.23

0.755

0.802

0.00

  1. Data are presented as mean ± standard deviation. Nominal P-values were assessed by Student’s t test, and the Benjamini–Hochberg procedure was applied on nominal P-values to control the false discovery rate (FDR).
Back to article page